Enrollment underway in second Avacta clinical program at first three specialist U.S. oncology centers Initial data from the trial expected later this year LONDON and PHILADELPHIA, March 31, 2026 (GLOBE NEWSWIRE) — Avacta Therapeutics (AIM: AVCT, “the Company”, “Avacta”), a clinical stage biopharmaceutical company developing pre|CISION®, a tumor-activated oncology delivery platform, is pleased to announce today, that the first patient has been treated in the FOCUS-01 trial, the multicenter, open-label Phase 1 clinical trial of FAP-Exd (AVA6103) in adults with selected advanced cancers. Avacta has very recently announced a £10 million fundraise by way of an oversubscribed placing and subscription to extend the Company’s cash runway into early Q1 2027, expected to provide sufficient funding beyond the...

EliteSiC technology boosts efficiency, power density and long-term reliability for Sineng’s high-power energy storage and solar inverter solutions Summary onsemi announced a new design win with Sineng Electric, which will feature onsemi’s latest‑generation hybrid power integrated module (PIM) in two utility‑scale renewable energy platforms. The PIM features onsemi’s FS7 insulated‑gate bipolar transistor (IGBT) and EliteSiC technology and will be used in Sineng’s next‑generation 430 kW liquid‑cooled energy storage systems (ESS) and 320 kW utility‑scale solar string inverter. Using onsemi’s technology, the Sineng solutions will deliver improved efficiency, higher power density, lower switching losses and improved thermal performance, advancing performance standards in utility-scale renewable energy applications. In benchmark testing against...

Status update on the project to adapt and strengthen the Casino Group’s financial structure Paris, 31 March 2026 Further to the Casino Group’s previous communications regarding the project to adapt and strengthen its financial structure, and in particular the publication of the proposals dated 16 March 20261, the Group announces that the key terms of the new proposals, as formulated to date, are set out in a presentation published today on its website (link). It is specified that all inside information relating to Casino Group that may have been disclosed to date by Casino to the various stakeholders subject to confidentiality agreements has been made public. The Group recalls that should such a transaction to adapt and strengthen the financial structure be completed, it would result in significant dilution for existing shareholders....

TomTom selected by LOCUS to provide high-precision traffic data for location intelligence platformTomTom selected by LOCUS to provide high-precision traffic data for location intelligence platformAMSTERDAM, The Netherlands, March 31, 2026 (GLOBE NEWSWIRE) — TomTom (TOM2), the specialist in mapping and location technology, today announced a partnership with LOCUS, a mobility analytics and location intelligence company, to integrate TomTom Traffic into the LOCUS platform. The integration of TomTom’s advanced traffic data with LOCUS’ analytical and modeling suite will strengthen outcomes for public and private sector customers, supporting the creation of smarter cities, optimized mobility networks, digital twins, and more resilient communities across North America. This integrated solution addresses the growing demand for...

BASEL, Switzerland, March 31, 2026 (GLOBE NEWSWIRE) —BioVersys strengthens its Ansamycin Chemistry platform and research on tackling difficult-to-treat non-tuberculous mycobacteria (NTM) diseases. BioVersys joins forces with Hackensack Meridian Health (HMH) and their Center for Discovery and Innovation (CDI) to advance ansamycin antimicrobial candidates through an exclusive collaboration and license agreement. HMH is a leading US not-for-profit health care network, and the largest in New Jersey. NTMs are ubiquitous environmental bacteria, predominately causing morbidity and death in those with long-term lung conditions, like bronchiectasis or cystic fibrosis and requiring long-term antibiotic combination treatments.BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development...

Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host diseaseRezurock is now approved in the EU for adults and children aged 12 years and older with chronic GVHD, providing a new medicine for patients with limited treatment optionsParis, March 31, 2026. The European Commission has granted a conditional marketing authorisation for Rezurock (belumosudil) for the treatment of chronic graft-versus-host disease (GVHD) in adults and in children aged 12 years and older with a body weight of at least 40 kg. The medicine is to be used when other treatment options provide limited clinical benefit, are not suitable, or have been exhausted. The conditional marketing authorisation is contingent on completion of a confirmatory, randomised, controlled study. This follows the positive opinion by the European Medicines Agency’s...

Civinity, a group providing building maintenance services and developing engineering and technology solutions, has signed a share purchase agreement to acquire 100% of the shares in Vilnius-based property management company Admeo.   Founded in 2012, Admeo provides property management and building maintenance services, focusing on qualified service delivery, high customer service standards, incident and emergency prevention, and the economical and efficient use of heating energy. The company has implemented an advanced fault registration and control system.   Admeo employs 15 people and manages approximately 140 residential apartment buildings and commercial properties in Vilnius. In 2024, the company generated nearly EUR 2.7 million in revenue.   “The residential property maintenance and management segment is strategically important to...

Inaugural store generates approximately RMB 235,000 in orders within first hour of opening; Company plans to expand to hundreds of locations across major agricultural producing regions over the next three years BEIJING, March 31, 2026 (GLOBE NEWSWIRE) — Yimutian Inc. (the “Company”) today announced the opening of the first Wolaicai Agricultural Service Station in Caoli Township, Fugou County, Henan Province, marking the commercial launch of the Company’s integrated farm-level service network. The inaugural location generated approximately RMB 235,000 in orders within its first hour of operation, based on unaudited preliminary figures, with more than 100 growers placing advance orders on opening day. The Company plans to expand the Wolaicai network to hundreds of locations across China’s major agricultural...